Partner Joshua Goodman spoke with The Minnesota Star Tribune for an article about a Federal Trade Commission (FTC) lawsuit to block a private equity firm’s proposed acquisition of Surmodics, a Minnesota-based medtech company—the first such case for the FTC under the second Trump administration.
Joshua told the publication that the case “demonstrates that the U.S. antitrust agencies are continuing to pay close attention to the potential antitrust impacts of deals in the health care sector in particular.”